Quantcast

Latest Replikins Ltd. Stories

2014-08-26 16:28:19

New Analysis Provides Basis for a Synthetic Mers CoV Blocker-Vaccine Candidate Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Mers CoV virus strains has revealed extensive conservation and sharing of specific Replikin structures back to 2012. This conservation and sharing of specific Replikin gene structures has permitted the formulation of a Synthetic Mers CoV Blocker-Vaccine(TM) candidate,...

2014-08-26 16:28:01

New Analysis Provides Basis for a Synthetic Influenza H1N1 Blocker-Vaccine Candidate, Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Influenza H1N1 virus strains has revealed extensive conservation and sharing of specific Replikin structures back to 1918. This conservation and sharing of specific Replikin gene structures has permitted the formulation of a Synthetic Influenza H1N1...

2014-08-26 16:27:59

Latest Analysis Provides Basis for a Synthetic Ebola Blocker-Vaccine Candidate, Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Ebola strains has revealed extensive conservation and sharing of specific Replikin structures back to 1976. This conservation and sharing of specific Replikin gene structures has paved the way for the development of a synthetic Ebola Blocker-Vaccine((TM)) candidate,...

2014-08-26 12:29:12

New Analysis Provides Basis for a Synthetic Dengue Blocker-Vaccine Candidate Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Dengue virus strains in Pubmed, has revealed extensive conservation and sharing of specific Replikin structures back to 1944. This conservation and sharing of specific Replikin gene structures has permitted the formulation of a Synthetic Dengue Blocker-Vaccine(TM)...

2014-08-26 12:28:34

New Analysis Provides Basis for a Synthetic Chikungunya Blocker-Vaccine Candidate Now Available for Testing LONDON, Aug. 26, 2014 /PRNewswire/ -- An analysis by Replikins, Ltd. of Pubmed data of the gene structures of all Chikungunya virus strains has revealed extensive conservation and sharing of specific Replikin structures back to 1953. This conservation and sharing of specific Replikin gene structures has permitted the formulation of a Synthetic Chikungunya Blocker-Vaccine(TM)...

2014-07-30 12:30:26

LONDON, July 30, 2014 /PRNewswire/ -- Replikins Ltd. today released new data on changes in the gene structure of the Ebola virus. Before the current outbreaks, the mean Ebola Reston gene Replikin Count (number of Replikins per 100 amino acids) between 1995 and 2002 was 1.1; the mean Replikin Count increased twofold in 2010, threefold in 2012, and sixteen-fold in 2013, thus predicting the current outbreaks in humans. In the past, this technology has been shown to be able to predict...

2014-05-19 08:28:40

Global Target Established: Replikins Identical in Humans and Camels; Anti-Mers-CoV Replikins Vaccine(TM) Available and Testing Has Started LONDON, May 19, 2014 /PRNewswire-USNewswire/ -- In an analysis of the human specimen gene sequences published Saturday, May 17 by PubMed, Bioradar UK, Ltd. found the Replikin gene sequences of the human Mers-CoV specimens in Florida and Indiana to contain identical Replikin gene sequences to those from other countries. These new findings followed BioRadar...

2014-05-16 12:27:03

Anti-Mers-CoV Synthetic Replikins Vaccine(TM) Available Now to Vaccinate Camels LONDON, May 16, 2014 /PRNewswire/ -- A Replikins analysis by Bioradar, Ltd of Mers-CoV in all isolates of the virus genes reported to date in Pubmed from both humans and camels has revealed specific shared gene Replikin structures that are not just homologous but are identical in the virus genes infecting both camels and humans, and conserved since 2012 in cases from all countries affected. Replikins, Ltd. has...

2014-04-30 20:23:52

Comparison with the Replikins Counts and Course of the SARS Outbreak of 2003 and the H1N1 Pandemic of 2009 LONDON, April 30, 2014 /PRNewswire/ -- Bioradar UK Ltd. and Replikins Ltd. announced today that the clinical course of the current Mers-CoV outbreak in southeast Asia is 'on course' according to the genomic Replikin Count predictions published on October 10, 2012 and on October 21, 2013. (Photo: http://photos.prnewswire.com/prnh/20140430/82706) Contact: Samuel Bogoch, MD,...

2014-03-11 23:04:38

New studies from Bioradar UK Ltd. and Replikins Ltd show that Pancreatic Cancer Joins Brain and Lung Cancer with the Highest Human Mortality Rates and Gene Replikin Counts; Thirty Times Greater Than the Gene Replikin Counts in H1N1 Influenza. LONDON, UK (PRWEB) March 11, 2014 Bioradar UK Ltd. and Replikins Ltd, the companies whose software analysis of virus gene Replikin Counts predicted the H1N1 influenza pandemic of 2009 one year in advance, announced today that their new studies show...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.